Knockdown of RFWD3 inhibited proliferation and increased secretion of IFN‐β at the cellular level, and repressed tumor growth with an increase in CD4+, CD8+, Granzyme B+/CD8+, IFN‐γ/CD8+, NK, and DC cells and a decrease in MDSCs. The gene discussed is CD4; the disease is neoplasm.